Antix Holdings (IMTH) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket
 


AnTix Holdings, Inc.  (IMTH)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare


Antix Holdings's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Antix Holdings's ROA in the fourth quarter of 2025?
AnTix Holdings, Inc. achieved a return on average assets (ROA) of 172.92 % in its fourth quarter of 2025, this is above IMTH's average return on assets of -14.05%.
Antix Holdings, Inc. assets over the 12 months ending in its fourth quarter of 2025 are valued at $1 million

ROA fell compared to the third quarter of 2025, despite the net income growth of % from the third quarter of 2025.

However, within the Healthcare sector AnTix Holdings, Inc. achieved the highest return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from 19 to 37.

What is ROA?



Return On Assets (Jun 30 2025)
IV. Quarter
(Mar 31 2025)
III. Quarter
(Dec 31 2024)
II. Quarter
(Sep 30 2024)
I. Quarter
(Jun 30 2024)
IV. Quarter
Y / Y Total Assets Change -80.43 % -77.14 % -76.65 % -86.48 % -68.8 %
Y / Y Net Income Change -49.59 % - - - -
Net Income (TTM) in million 1 5 4 5 5
Return On Assets (TTM) 172.92 % 462.23 % 199.11 % 172.81 % 146.49 %
IMTH's Total Ranking # 37 # 19 # 33 # 34 # 42
Total Assets (TTM) in million 0 1 1 1 1
Seq. Total Assets Change -76.49 % 5.24 % 65.14 % -52.11 % -72.53 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry #
Sector #
Overall # 0

Return On Assets Statistics
High Average Low
443.94 %
-14.05 %
-973.89 %
(Mar 31 2025)   (Jul 31 2012)





Financial Statements
Antix Holdings's Assets $ 0 million IMTH's Balance sheet
Antix Holdings's Income $ 3 million Quarterly IMTH's Income Statement
IMTH's Income by Division See IMTH's Income by Division



Annual Return On Assets (Jun 30 2025)
FY 2025
(Jun 30 2024)
FY 2024
(Jun 30 2023)
FY 2023
(Jun 30 2022)
FY 2022
(Jun 30 2020)
FY 2021
Y / Y Total Assets Change -80.43 % -68.8 % -3.46 % 530012.5 % -99.56 %
Total Assets in million 0 1 4 4 0
Y / Y Net Income Change - - - - -
Net Income in million 1 -8 4 -18 0
Annual Return On Assets 507.56 % -621.44 % 89.1 % -425.82 % -61212.5 %




Comment on IMTH's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 507.56 % compared to prior year, due to annual net income growth of % to $1.27 million, and due to decline of value in Antix Holdings's assets by -80.43 % to $0.25 million, compared to $0.25 a year before.


More Return On Assets Ratios
IMTH's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IMTH's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IMTH's Competitors
Subscribers only: Roa for Antix Holdings's Suppliers
Subscribers only: Return On Assets for IMTH's Customers

You may also want to know
IMTH's Roi IMTH's Inventory Turnover Ratio IMTH's Growth Rates IMTH's Dividend Comparisons
IMTH's Profitability Ratios IMTH's Asset Turnover Ratio IMTH's Dividend Growth
IMTH's Roe IMTH's Valuation Ratios IMTH's Financial Strength Ratios IMTH's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2025, within Healthcare Sector ROA
Vystar Corporation  403.57 %
Glucotrack Inc   402.86 %
Silexion Therapeutics Corp  286.41 %
Pavmed Inc   172.62 %
Capforce Inc   165.71 %
Semnur Pharmaceuticals Inc   145.63 %
AnTix Holdings, Inc.  136.27 %
Emmis Acquisition Corp   107.50 %
Oak Woods Acquisition Corp  96.53 %
Rigel Pharmaceuticals Inc  57.03 %
Seres Therapeutics Inc   54.88 %
Gridai Technologies Corp  53.25 %
Exelixis Inc   48.25 %
Earth Science Tech Inc   44.59 %
Adma Biologics Inc   42.90 %
Coherus Oncology inc   40.76 %
Entera Bio Ltd   40.32 %
Agios Pharmaceuticals Inc   40.12 %
Abeona Therapeutics Inc   39.81 %
Biomx Inc  39.73 %
Dariohealth Corp   39.03 %
Stablecoin Development Corporation  38.52 %
Interpace Biosciences Inc   37.22 %
Cytomx Therapeutics Inc   36.01 %
Medinotec Inc   35.97 %
Siga Technologies Inc  35.65 %


Date modified: 2026-08-30T22:30:53+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.